Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response
出版年份 2019 全文链接
标题
Spironolactone inhibits the growth of cancer stem cells by impairing DNA damage response
作者
关键词
-
出版物
ONCOGENE
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-01-09
DOI
10.1038/s41388-018-0654-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Spironolactone and the risk of urinary tract cancer in patients with hypertension
- (2017) Ya-Wen Chuang et al. JOURNAL OF HYPERTENSION
- Cancer stem cells: The root of tumor recurrence and metastases
- (2017) Claudia Peitzsch et al. SEMINARS IN CANCER BIOLOGY
- Novel approach to target cancer stem cells for therapy
- (2016) Ajumeera Rajanna MEDICAL HYPOTHESES
- Balancing efficacy of and host immune responses to cancer therapy: the yin and yang effects
- (2016) Yuval Shaked Nature Reviews Clinical Oncology
- DNA repair targeted therapy: The past or future of cancer treatment?
- (2016) Navnath S. Gavande et al. PHARMACOLOGY & THERAPEUTICS
- The linker histone H1.0 generates epigenetic and functional intratumor heterogeneity
- (2016) C. M. Torres et al. SCIENCE
- Increased global transcription activity as a mechanism of replication stress in cancer
- (2016) Panagiotis Kotsantis et al. Nature Communications
- Cancer stem cells: a metastasizing menace!
- (2016) Saurabh Bandhavkar Cancer Medicine
- Mineralocorticoid receptors are present in skeletal muscle and represent a potential therapeutic target
- (2015) Jessica A. Chadwick et al. FASEB JOURNAL
- Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition
- (2015) Lynnette R. Ferguson et al. SEMINARS IN CANCER BIOLOGY
- Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage
- (2015) Chi-Hsuan Chang et al. Stem Cell Reports
- A Small Molecule Screen Identifies an Inhibitor of DNA Repair Inducing the Degradation of TFIIH and the Chemosensitization of Tumor Cells to Platinum
- (2014) Sergey Alekseev et al. CHEMISTRY & BIOLOGY
- A high-throughput chemical screen with FDA approved drugs reveals that the antihypertensive drug Spironolactone impairs cancer cell survival by inhibiting homology directed repair
- (2014) Or David Shahar et al. NUCLEIC ACIDS RESEARCH
- DNA-Damaging Agents in Cancer Chemotherapy: Serendipity and Chemical Biology
- (2013) Kahlin Cheung-Ong et al. CHEMISTRY & BIOLOGY
- Modulation of NKG2D ligand expression and metastasis in tumors by spironolactone via RXRγ activation
- (2013) Wai-Hang Leung et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Induction of G2/M arrest, caspase activation and apoptosis by α-santonin derivatives in HL-60 cells
- (2013) José Roberto Oliveira Ferreira et al. TOXICOLOGY IN VITRO
- Quiescence and attenuated DNA damage response promote survival of esophageal cancer stem cells
- (2012) Yulin Chen et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- In vitro generation of human cells with cancer stem cell properties
- (2011) Paola Scaffidi et al. NATURE CELL BIOLOGY
- Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma Cells
- (2010) B. Campos et al. CLINICAL CANCER RESEARCH
- A Comparison of the Aldosterone-blocking Agents Eplerenone and Spironolactone
- (2008) Allan Struthers et al. CLINICAL CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search